RxDoctor Payments Data

Evan Ellenberg, PA

Family Medicine · Panama City Beach, FLNPI 1225420334

Payments from drug & device makers

$837in general payments, 2019–2025

Across 63 payments — averaging $13.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$353
  • AbbVie$174
  • Novo Nordisk$169
  • Boehringer Ingelheim$79
  • AstraZeneca$23
  • Amgen$22
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$837100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC34$353
AbbVie9$174
Novo Nordisk12$169
Boehringer Ingelheim4$79
AstraZeneca2$23
Amgen1$22
Eisai Inc.1$16

How this compares

$837 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$43,530
Medicare patients
133
Services billed
1,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide33$42,485
OzempicSemaglutide29$28,340
EntrestoSacubitril/Valsartan23$26,065
Combivent RespimatIpratropium/Albuterol Sulfate12$6,764
Atorvastatin Calcium142$1,200
Levothyroxine Sodium91$1,164
Omeprazole69$1,151
Albuterol Sulfate HfaAlbuterol Sulfate30$979
Rosuvastatin Calcium53$924
Testosterone Cypionate29$919
Amlodipine Besylate74$720
Ezetimibe20$712
Valsartan38$653
Metoprolol Succinate42$573
Duloxetine Hcl17$554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$353$42,48533 claims
Novo NordiskOzempic$169$28,34029 claims
Boehringer IngelheimCombivent Respimat$79$6,76412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Panama City Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →